Advances in Hepatitis: Prevention, Treatment, and Global Health Impact
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: 28 January 2026 | Viewed by 97
Special Issue Editors
Interests: HCV; hepatitis c; HBV; hepatitis B; covid-19; sars-cov-2; microbiome; MASLD
Interests: hepatitis; hepatitis B; hepatitis C; liver disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Hepatitis continues to pose a substantial global health challenge, despite remarkable advancements in its prevention, diagnosis, and treatment. The advent of direct-acting antivirals (DAAs) has revolutionized hepatitis C therapy, yielding cure rates above 95%, while effective vaccination programs have curbed the spread of hepatitis B. However, inequities in access to care, particularly in low- and middle-income countries, hinder progress toward global elimination goals. This Special Issue aims to highlight innovative strategies in prevention, novel therapeutic developments, public health initiatives, and policy approaches addressing viral hepatitis. We welcome original research and reviews that explore molecular mechanisms, clinical trials, epidemiological trends, and health equity efforts. Our shared objective is to support global efforts aligned with the WHO’s 2030 targets and ultimately reduce the burden of liver disease worldwide.
Dr. Michał Brzdęk
Prof. Dr. Dorota Zarębska-Michaluk
Dr. Krystyna Dobrowolska
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatitis B
- hepatitis C
- liver disease
- direct-acting antivirals (DAAs)
- global health
- public health policy
- viral hepa-titis elimination
- health disparities
- cirrhosis
- vaccination programs
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
